About
Achelios Therapeutics develops topically delivered pharmaceutical formulations that enable effective transdermal delivery of NSAIDs for localized treatment of pain and inflammation, with a focus on chronic temporomandibular joint disorder (TMJD) and other inflammatory joint pains.
Explore Achelios Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.